12
Views
12
CrossRef citations to date
0
Altmetric
Original Article

Bone turnover in postmenopausal women after withdrawal of estrogen/gestagen replacement therapy

, , , &
Pages 169-175 | Published online: 07 Jul 2009

References

  • Nordin B. E. C., Crilly R. G., Smith D. A. Osteoporosis. Metabolic Bone and Stone Disease, B. E. C. Nordin. Churchill Livingstone, Edinburgh 1984; 1
  • Nordin B. E. C., Horsman A., Crilly R. G., Marshall D. H., Simpson M. Treatment of spinal osteroporosis in postmenopausal women. Br. Med. J. 1980; 280: 451
  • Lindsay R., Hart D. M., Aitken J. M., MacDonald E. B., Anderson J. B., Clarke A. C. Long-term prevention of postmenopausal osteoporosis by estrogen. Lancet 1973; i: 1038
  • Recker R. R., Saville P. D., Heaney R. P. Effect of estrogens and calcium carbonate on bone loss in postmenopausal women. Ann. Intern. Med. 1977; 87: 649
  • Nachtigall L. E., Nachtigall R. H., Nachtigall R. D., Beckman E. M. Estrogen replacement therapy. I. A 10-year prospective study in relationship to osteoporosis. Obstet. Gynecol. 1979; 53: 277
  • Christiansen C., Christensen M. S., McNair P., Hagen C., Stocklund K.-E., Transbøl I. Prevention of early postmenopausal bone loss: controlled 2-year study in 315 normal females. Eur. J. Clin. Invest. 1980; 10: 273
  • Ettinger B., Genant H. K., Cann C. (1984) Long-term estrogen therapy prevents fractures and preserves bone mass. Osteoporosis. Proceedings of the Copenhagen International Symposium on Osteoporosis. 1984, C. Christiansen, C. D. Arnaud, B. E. C. Nordin, A. M. Parfitt, W. A. Peck, B. L. Riggs. Copenhagen, 563
  • Fogelman I., Bessent R. G. Age-related alterations in skeletal metabolism—24–hr whole-body retention of diphosphonate in 250 normal subjects: concise communication. J. Nucl. Med. 1982; 23: 296
  • Delmas P. D., Stenner D., Wahner H. W., Mann K. G., Riggs B. L. Increase in serum bone γ-carboxyglutamic acid protein with aging in women. J. Clin. Invest. 1983; 71: 1316
  • Thomsen K., Riis B., Christiansen C. Effect of estrogen/ gestagen and 24R, 25-dihydroxy-vitamin D3 therapy on bone formation in postmenopausal women. J. Bone Min. Res. 1986; 1: 503
  • Lindsay R., Hart D. M., MacLean A., Clark A. C., Kraszewski A., Garwood J. Bone response to termination of estrogen treatment. Lancet 1978; i: 1325
  • Christiansen C., Christensen M. S., Transbeøl I. Bone mass in postmenopausal women after withdrawal of oestrogen/gestagen replacement therapy. Lancet 1981; i: 459
  • Fogelman I., Bessent R. G., Cohen H. N., Hart D. M., Lindsay R. Skeletal uptake of diphosphonate. Method for prediction of postmenopausal osteoporosis. Lancet 1980; ii: 667
  • Riis B. J., Thomsen K., Christiansen C. Does vitamin 24R, 25(OH)2D3 prevent postmenopausal bone loss?. Calcif Tissue Int. 1986; 39: 128
  • Thomsen K., Nilas L., Mogensen T., Christiansen C. Determination of bone turnover by urinary excretion of 99mTc-MDP. Eur. J. Nucl. Med. 1986; 12: 342
  • Thomsen K., Gotfredsen A., Christiansen C. Bone turnover in healthy adults measured by whole body retention and urinary excretion of 99Tc-MDP. Normalization by bone mass. Scand.J. Clin. Lab. Invest. 1986; 46: 587
  • Johansen J. S., Mølholm Hansen J. E., Christiansen C. A radioimmunoassay for bone Gla-protein (BGP) in human plasma. Acta Endocrinologica 1987, In press
  • The committee on enzymes of the Scandinavian Society for Clinical Chemistry and Clinical Physiology. Recommended methods for determination of four enzymes in blood. Scand.J. Clin. Invest. 1974; 33: 291
  • Pødenphant J., Larsen N.-E., Christiansen C. An easy and reliable method for determination of urinary hyroxyproline. Clin. Chim. Acta 1984; 142: 145
  • Judd H. L., Cleary R. E., Creasman W. T., Figge D. C., Kase N., Rosenwaks Z., Tasatz G. E. Estrogen replacement therapy. Am. J. Obstet. Gynecol. 1981; 58: 267
  • Brincat M., De Trafford J. C., Lafferty K., Studd J. W. W. Peripheral vasomotor control and menopausal flushing—a preliminary report. BY.J. Obstet. Gynaecol. 1984; 91: 1107
  • Riis B. J., Thomsen K., Strøm V., Christiansen C. The effect of percutaneous estradiol and natural progesterone on postmenopausal bone loss. Am. J. Obstet. Gynecol. 1987, In press
  • Francis M. D. The inhibition of calcium hydroxyapatite crystal growth by polyphosphonates and polyphosphates. Calcif. Tissue Res. 1969; 3: 151
  • Fogelman I. Skeletal uptake of diphosphonate: A review. Eur. J. Null. Med. 1980; 5: 473
  • Guillemart A., Besnard J.-C., Le Pape A., Galy G., Fetissoff F. Skeletal uptake of pyrophosphate labeld with technetium-95m and technetium-96m, as evaluated by autoradiography. J. Nucl. Med. 1978; 19: 895
  • Christiansen S. H., Krogsgaard O. W. Localization of Tc-99m MDP in epiphyscal growth plates of rats. J. Nucl. Med. 1981; 22: 237
  • Frost H. M. Dynamics of bone remodeling. Bone Biodynamics, H. M. Frost. Little, Brown and Co., Boston 1964; 315
  • Parfitt A. M. Quantum concept of bone remodeling and turnover. Implications for the pathogenesis of osteoporosis. Calcif. Tissue Int. 1979; 28: 1
  • Hutchinson T. A., Polansky S. M., Feinstein A. R. Post-menopausal oestrogens protect against fractures of hip and distal radius. A case-control study. Lancet 1979; ii: 705
  • Jensen G. F., Christiansen C., Transbøl I. Fracture frequency and bone preservation in postmenopausal women treated with estrogen. Obstet. Gynecol. 1982; 60: 493
  • Weis N. S., Ure C. L., Ballard J. H., Williams B. A., Daling J. K. Decreased risk of fractures of the hip and lower forearm with postmenopausal use of estrogen. N. Engl. J. Med. 1980; 303: 1195

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.